Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Advanced Proteome Therapeutics Corporation (APC.V)

TSXV - TSXV Real Time Price. Currency in CAD
0.04000.0000 (0.00%)
At close: 10:02AM EST
Advertisement

Advanced Proteome Therapeutics Corporation

8337 Eastlake Drive
Suite 104
Burnaby, BC V5A 4W2
Canada
604-690-3797
https://www.advancedproteome.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Paul John Courtney WoodwardPres, CEO, Director & Member of Corp. Advisory Board70k25k1962
Mr. Kenneth Clifford Phillippe C.A., B.Com., B.Comm, CPA, CA, CPAChief Financial Officer19.57kN/A1952
Mr. Martin John Courtney WoodwardSec. & Independent DirectorN/A22.5k1968
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Advanced Proteome Therapeutics Corporation, through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the United States. The company develops and commercializes a platform for the chemical modification of protein therapeutics. Its platform is dedicated to applications in the field of antibody drug conjugates, as well as focused on protein conjugates and immunomodulation. The company is headquartered in Burnaby, Canada.

Corporate Governance

Advanced Proteome Therapeutics Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement